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GoLoco motif proteins bind to the inhibitory Gi subclass of
G-protein  subunits and slow the release of bound GDP; this
interaction is considered critical to asymmetric cell division
and neuro-epithelium and epithelial progenitor differentia-
tion. To provide protein tools for interrogating the precise cel-
lular role(s) of GoLoco motif/Gi complexes, we have em-
ployed structure-based protein design strategies to predict
gain-of-function mutations that increase GoLoco motif bind-
ing affinity. Here, we describe fluorescence polarization and
isothermal titration calorimetry measurements showing three
predicted Gi1 point mutations, E116L, Q147L, and E245L;
each increases affinity for multiple GoLoco motifs. A compo-
nent of this affinity enhancement results from a decreased rate
of dissociation between the G mutants and GoLoco motifs.
For Gi1Q147L, affinity enhancement was seen to be driven by
favorable changes in binding enthalpy, despite reduced contri-
butions from binding entropy. The crystal structure of
Gi1Q147L bound to the RGS14 GoLoco motif revealed disor-
der among three peptide residues surrounding a well defined
Leu-147 side chain. Monte Carlo simulations of the peptide in
this region showed a sampling of multiple backbone confor-
mations in contrast to the wild-type complex. We conclude
that mutation of Glu-147 to leucine creates a hydrophobic sur-
face favorably buried upon GoLoco peptide binding, yet the
hydrophobic Leu-147 also promotes flexibility among residues
511–513 of the RGS14 GoLoco peptide.
Protein-based therapeutics and tools are increasingly uti-
lized for manipulating cell biology (1–5). A vital aspect of
their effective function is affinity for a target protein or ligand.
An effective approach for enhancing the affinity of protein/
protein interactions is structure-based computational predic-
tion of affinity-enhancing point mutations (6–9). The devel-
opment of reliable in silico procedures promises to provide a
more efficient means of protein design than labor-intensive
combinatorial screening techniques such as phage display or
ribosome display (10–12). Previously, a structure-based pro-
tocol for predicting affinity-enhancing point mutations was
developed (7), in part using as a template the high-resolution
crystal structure of the heterotrimeric G-protein subunit Gi1
in complex with the RGS14 (regulator of G-protein signaling
14) GoLoco motif (13). Residues at the protein/peptide bind-
ing surface were sequentially mutated to nonpolar amino ac-
ids in silico, producing 33 predicted affinity-enhancing muta-
tions. Four of six experimentally tested mutations to either
Gi1 or the GoLoco motif enhanced binding affinity, as pre-
dicted by Rosetta (7).
As a critical component of seven-transmembrane domain
receptor signaling, G subunits normally cycle between an
inactive GDP-bound state and an active GTP-bound state
(reviewed in Refs. 14 and 15). GoLoco motif proteins such as
LGN, AGS3, RGS12, and RGS14 act as guanine nucleotide
dissociation inhibitors, specifically for the adenylyl cyclase
inhibitory subclass of G subunits (reviewed in Refs. 16 and
17). GoLoco motifs prevent GDP dissociation by binding
across the Ras-like and all-helical domains of G, as well as by
contributing an arginine side chain from the highly conserved
(E/D)QR GoLoco triad (16) to contacts made to the bound
guanosine diphosphate (13). Not only are GoLoco motif-con-
taining proteins thought to modulate seven-transmembrane
domain receptor signaling in various physiological responses
(18–20), but these proteins are also critical to cell fate deter-
minant sorting and cell division processes in multiple con-
texts across multiple species (21–24). Highlighting the value
of mutation-derived affinity modulation to cell biological ap-
plications, a Gi1N149I mutant with selective loss of GoLoco
motif affinity has recently provided direct evidence for the
Gi/GoLoco protein interaction in these cell division pro-
cesses (25, 26).
We previously predicted that mutation to leucine of one of
three polar residues, Glu-116, Gln-147, or Glu-245, on the
surface of Gi1 enhances binding of Gi1-GDP to the RGS14
GoLoco motif (7, 27). Although the algorithms implemented
in the Rosetta program predict a favorable change in the
Gibbs free energy of binding, our computational tools do not
provide a clear mechanism of affinity enhancement. Knowl-
edge of changes in the thermodynamic and/or kinetic param-
eters of binding, such as the rate of dissociation, will be im-
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portant in the future application of these computational
design strategies to biological and therapeutic questions.
Here, we assessed the effects of these predicted Gi1/GoLoco
affinity-enhancing mutations on the kinetics and thermody-
namics of binding using fluorescence polarization, isothermal
titration calorimetry, and surface plasmon resonance. Al-
though mutations that promote binding to a target protein
are desirable, protein design applications often require the
preservation of other protein functions. Accordingly, we also
determined the effects of these three affinity-enhancing muta-
tions on the nucleotide cycle of Gi1, including GTP binding
and hydrolysis. To further elucidate the molecular mecha-
nism of affinity enhancement for one mutant, we determined
the x-ray crystal structure of Gi1Q147L-GDP bound to the
RGS14 GoLoco motif. In addition, we investigated the confor-
mational flexibility of the GoLoco peptide backbone and side
chains surrounding the Leu-147 residue of the Gi1 mutant
using Monte Carlo simulations.
EXPERIMENTAL PROCEDURES
Chemicals and Other Assay Materials—Unless otherwise
noted, all chemicals were the highest grade available from
Sigma or Fisher Scientific. Peptides were synthesized by Fmoc
(N-(9-fluorenyl)methoxycarbonyl) group protection, purified
via HPLC, and confirmed using mass spectrometry by the
Tufts University Core Facility (Medford, MA). Peptide se-
quences are as follows: FITC-GPSM2(GL2), FITC--alanine-
NTDEFLDLLASSQSRRLDDQRASFSNLPGLRLTQNSQS-
amide; FITC-RGS12 GoLoco, FITC--alanine-DEAEEFFELI-
SKAQSNRADDQRGLLRKEDLVLPEFLR-amide; FITC-
RGS14 GoLoco, FITC--alanine-SDIEGLVELLNRVQSSGA-
HDQRGLLRKEDLVLPEFLQ-amide; and RGS14 GoLoco,
DIEGLVELLNRVQSSGAHDQRGLLRKEDLVLPEFLQ-amide.
Protein Expression and Purification—For biochemical ex-
periments, N-terminally truncated, hexahistidine-tagged WT
and mutant Gi1 proteins were expressed and purified as de-
scribed previously (28). Point mutations were made using
QuikChange site-directed mutagenesis (Stratagene, La Jolla,
CA). For crystallization, the Gi1Q147L mutant was expressed
and purified as described previously (29). Purified Gi1Q147L
was concentrated to 15 mg/ml and stored in crystallization
buffer (10 mM Tris (pH 7.5), 1 mM magnesium chloride, 5%
(v/v) glycerol, and 5 mM DTT).
Fluorescence Polarization Measurements—All polarization
experiments were conducted using a PHERAstar microplate
reader (BMG Labtech, Offenburg, Germany). Excitation
wavelength was 485  6 nm, and emission was recorded at
520  15 nm. Gains of the parallel and perpendicular chan-
nels were calibrated so that 350 pM FITC probe alone had a
polarization of 35 milli-Polarization units (mP) for each
experiment. All experiments were conducted at 25 °C in trip-
licate using 96-well black-bottom plates (Costar, Corning,
NY). The final volume of each well was brought to 180 l with
PheraBuffer (10 mM Tris (pH 7.5), 150 mM NaCl, 100 M
GDP, and 0.05% (v/v) Nonidet P-40). For experiments con-
ducted in the presence of the transition-state mimetic, alumi-
num magnesium tetrafluoride (AMF),4 an additional 10 mM
MgCl2, 10 mM NaF, and 30 M AlCl3 were added to the stand-
ard PheraBuffer. Polarization was determined from raw inten-
sity values of the parallel and perpendicular channels using
PHERAstar Version 1.60 software (BMG Labtech). Binding
isotherms were fit and equilibrium dissociation constants
were determined using GraphPad Prism Version 5.0 as de-
scribed previously (28).
Surface Plasmon Resonance Assays—Optical detection of
protein/protein interactions by surface plasmon resonance
was performed using a Biacore 3000 (GE Healthcare). Car-
boxymethylated dextran (CM5) sensor chips (GE Healthcare)
with covalently bound anti-GST antibody surfaces were cre-
ated as described previously (30). The GST-GoLoco fusion
proteins GST-RGS12 (amino acids 1184–1228) (29), GST-
RGS14 (amino acids 497–532) (29), and GST-GPSM2(GL2)
(31), as well as GST alone (serving as a negative control), were
loaded onto separate surfaces to levels of 1372, 963, 1290, and
1061 resonance units (RU), respectively. All experiments were
performed with the sensor surface, fluidics, and pump equili-
brated with Biacore running buffer (10 mM HEPES (pH 7.4),
150 mM NaCl, 0.05% (v/v) Nonidet P-40, 100 M GDP, and 50
M EDTA). Injections of 200 l of WT or mutant Gi1 at 50
M for kinetic analyses were performed using the KINJECT
command with a dissociation phase of 2000 s at a flow rate of
40 l/min. The surface was regenerated between runs by re-
moval of bound Gi1 using 325-l injections of AMF buffer
(Biacore running buffer with an additional 10 mM MgCl2, 10
mM NaF, and 30 M AlCl3). Nonspecific binding to the GST
only-loaded surface was subtracted from each curve (BIA-
evaluation Version 3.0 software, GE Healthcare). To establish
off-rates, dissociation-phase sensorgrams were normalized to
percent bound, and the averages of triplicate experiments
were fit to a single exponential function for dissociation with-
out constraints using Prism Version 5.0.
Nucleotide Binding and Hydrolysis Assays—The
[35S]GTPS filter-binding assay used to measure rates of
spontaneous GDP release was conducted as described previ-
ously (32). Briefly, WT or mutant Gi1 (100 nM) was incu-
bated in assay buffer (20 mM Tris (pH 7.5), 1 mM C12E10, 1 mM
DTT, 1 mM EDTA, 100 mM NaCl, and 25 mM MgCl2) or non-
specific buffer (assay buffer plus 100 M GTPS) at 20 °C.
Radioligand binding was initiated by the addition of 6.25 nM
[35S]GTPS. At timed intervals, 100-l aliquots of the reac-
tion were filtered through nitrocellulose membranes and
washed four times with 7.5 ml of ice-cold wash buffer (20 mM
Tris (pH 7.5), 120 mM NaCl, and 25 mM MgCl2). Filters were
dried under a vacuum before measuring -radiation via liquid
scintillation counting.
Intrinsic GTP hydrolysis rates of Gi1 subunits were as-
sessed by monitoring the production of 32P-labeled inorganic
phosphate during a single round of GTP hydrolysis as de-
scribed previously (33). In brief, WT or mutant Gi1 (100 nM)
was incubated for 10 min at 20 °C with 1  106 cpm of
4 The abbreviations used are: AMF, aluminum magnesium tetrafluoride;
GTPS, guanosine 5-O-(thiotriphosphate); ITC, isothermal titration calo-
rimetry; FP, fluorescence polarization; CI, confidence interval.
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[-32P]GTP (specific activity of 6500 dpm/Ci; PerkinElmer
Life Sciences) in reaction buffer (50 mM Tris (pH 7.5), 0.05%
(v/v) C12E10, 1 mM DTT, 10 mM EDTA, 100 mM NaCl, and 5
g/ml BSA). The nucleotide-loaded protein was then chilled
on ice for 5 min prior to initiation of hydrolysis by the addi-
tion of 10 mM MgCl2 and 100 M GTPS (final concentra-
tions). At timed intervals, 100-l aliquots were quenched in
900 l of charcoal slurry (5% (w/v) activated charcoal in 50
mM H3PO4 (pH 3.0)) and centrifuged at 4 °C for 10 min at
4000  g. Subsequently, the -radiation of 600-l aliquots of
the supernatant was counted via liquid scintillation.
Intrinsic Tryptophan Fluorescence Measurements of G
Activation—Changes in tryptophan fluorescence of Gi1 sub-
units were measured to assess activation by the transition-
state mimetic GDPAlF4. Activation of Gi1 results in trans-
location of Trp-211, a residue in the conformationally flexible
switch II region, to a hydrophobic pocket; the change in envi-
ronment results in an increased quantum yield of Trp-211
fluorescence (34, 35). Tryptophan fluorescence of WT or mu-
tant Gi1 (1 M) was measured using a POLARstar Omega
plate reader (BMG Labtech) in 187 l of assay buffer (100 mM
NaCl, 100 M EDTA, 2 mM MgCl2, 2 M GDP, and 20 mM
Tris (pH 8.0)). Intrinsic fluorescence was measured using a
280-nm excitation filter and 350-nm emission filter (each
with 10-nm cutoffs). After a 20-s equilibration at ambient
temperature, activation was induced by sequential injections
of 8 l of 0.5 M NaF and 5 l of 1.2 mM AlCl3 to each well.
Tryptophan fluorescence was recorded for 2 min following
activation. Fluorescence intensity traces shown represent the
average of experiments performed in triplicate.
Isothermal Titration Calorimetry—Isothermal titration cal-
orimetry (ITC) was performed using a MicroCalTM Auto-
ITC200 system (GE Healthcare). WT and mutant Gi1 sub-
units were subjected to size-exclusion chromatography in ITC
buffer (50 mM HEPES (pH 7.5), 150 mM NaCl, 10 M GDP, 5%
(v/v) glycerol, and 0.005% (v/v) -mercaptoethanol) and sub-
sequently concentrated to 30 M using a VivaSpin 20 ultrafil-
tration spin column (Sartorius Stedim Biotech, Göttingen,
Germany) at 4 °C and 3000  g. Lyophilized RGS14 GoLoco
peptide was dissolved in ITC buffer to a concentration of 350
M. Titrations were performed at 25 °C and consisted of 20
2-l injections of peptide into WT Gi1 or Gi1Q147L solu-
tions at 250-s intervals. Binding isotherms and curve fittings
were obtained using Origin for ITC analysis software (Micro-
Cal). Enthalpy of binding was determined for three titrations
each of RGS14 GoLoco peptide into solutions of wild-type
Gi1 or Gi1Q147L, and average values were compared with a
Student’s t test using Prism Version 5.0. Because ITC sensitiv-
ity did not allow us to approach a Gi1 or peptide concentra-
tion near the KD, Gibbs free energy of binding was calculated
from the more accurate fluorescence polarization binding
affinity measurements, using G  R(T)ln(1/KD), where R
is the universal gas constant and T is temperature in Kelvin.
Entropy of binding was then estimated with S  (H 
G)/T, where H is the average enthalpy of binding derived
from isothermal titrations.
Crystallization and Structure Determination—The complex
of Gi1Q147L and RGS14 GoLoco peptide was obtained by
mixing Gi1Q147L and GoLoco peptide to concentrations of
400 and 600 M, respectively, in 10 mM Tris (pH 7.5), 1 mM
MgCl2, 10 M GDP, 5% (v/v) glycerol, and 5 mM DTT. Crys-
tals of the Gi1Q147LGDP/GoLoco peptide heterodimer were
obtained by vapor diffusion from hanging drops containing a
1:1 (v/v) ratio of protein/peptide solution to well solution
(1.5–1.6 M ammonium sulfate, 100 mM MgCl2, 100 mM so-
dium acetate (pH 4.8), and 10% (v/v) glycerol). Crystals
(200  200  50 m) formed in 1–4 days at 18 °C exhibited
the symmetry of space group P2221 (a  70.3, b  83.7, and
c  190.1 Å,       90°) and contained two Gi1Q147L/
GoLoco heterodimers in the asymmetric unit. For data collec-
tion at 100 K, crystals were transferred to well solution sup-
plemented with 25% saturated sucrose for 30 s, followed by
plunging into liquid nitrogen. A native data set was collected
at the SER-CAT 22-BM beamline at the Advanced Photon
Source (Argonne National Laboratory). Data were processed
using the HKL-2000 program (36). The crystal structure of
the WT Gi1/RGS14 GoLoco heterodimer (Protein Data
Bank code 2OM2 (7)), excluding the GoLoco motif peptide,
nucleotide, waters, and magnesium, was used as a search
model for molecular replacement using the Phaser program
(37). Refinement was carried out using the Refmac5 program
(38), consisting of conjugate gradient minimization and re-
finement of individual atomic displacement and translation-
libration-screw parameters, interspersed with manual revi-
sions of the model using the Coot program (39). The current
model contains two Gi1Q147LGDP/GoLoco peptide het-
erodimers in the asymmetric unit. For data collection and
refinement statistics and a list of residues that could not be
located in the electron density, see supplemental Table S1. All
structural images were made with PyMOL (Schrödinger LLC,
Portland, OR) unless indicated otherwise.
RESULTS AND DISCUSSION
Comparing Different Point Mutations in Gi1 That Enhance
Affinity for GoLoco Motifs—Three polar-to-nonpolar point
mutations in Gi1 (E116L, Q147L, and E245L) have been de-
scribed individually (7, 27) as enhancing GoLoco motif bind-
ing affinity; the location of these three positions within Gi1 is
highlighted in supplemental Figs. S1 and S2. To determine
and compare directly the affinities of these three separate
Gi1 point mutants (Gi1E116L, Gi1Q147L, and Gi1E245L) for
the GoLoco motif of RGS14, we used a synthetic FITC-RGS14
GoLoco motif peptide probe in fluorescence polarization (FP)
binding assays similar to those performed with RGS12 and
WT Gi1 (28). Holding the peptide concentration at 350 pM,
we added increasing concentrations of WT or mutant Gi1
protein (30 pM to 200 nM) and generated equilibrium binding
isotherms (Fig. 1). The dissociation constants (KD) were de-
termined to be 14, 1.6, 2.3, and 0.69 nM for GDP-bound
Gi1WT, Gi1E116L, Gi1Q147L, and Gi1E245L, respectively.
These results confirm our earlier reports of affinity enhance-
ment obtained with a tenascin-GoLoco fusion FP probe (7)
and, for Gi1E245L, mutation in the context of other affinity-
modifying changes (27). Consistent with the selective binding
of GoLoco motifs to ground-state Gi subunits (i.e. GiGDP)
(reviewed in Ref. 16), the transition-state mimetic form (i.e.
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GDPAlF4-bound) of Gi1WT, Gi1E116L, and Gi1Q147L did
not demonstrate any appreciable binding to the RGS14
GoLoco motif (Fig. 1); however, the aluminum tetrafluoride-
activated Gi1E245L was observed to bind the FITC-RGS14
GoLoco FP probe with a dissociation constant of 47 nM.
These affinity-enhancing mutations of Gi1 were computa-
tionally predicted based on the known structure of the WT
Gi1/RGS14 GoLoco motif heterodimer (7, 27). To determine
whether these mutations differentially affected binding to
other known GoLoco motifs, we performed similar FP assays
with GoLoco motifs from RGS12 and GPSM2 (the latter pro-
tein is also known as LGN or mammalian Pins). Both
Gi1E116LGDP and Gi1E245LGDP had enhanced affinities
toward the RGS12 and GPSM2 GoLoco motif FP probes,
whereas the KD values obtained for Gi1Q147LGDP were sta-
tistically indistinguishable from those for Gi1WTGDP for
both probes (Fig. 2).
To determine the dissociation rates (koff) of the WT and
mutant Gi1 subunits from their respective complexes with
the RGS12, RGS14, and GPSM2(GL2) GoLoco motifs, we
used surface plasmon resonance biosensors. We generated
surfaces of GST-RGS12 GoLoco, GST-RGS14 GoLoco, and
GST-GPSM2(GL2) fusion proteins, each bound to separate
anti-GST antibody-coated biosensor flow cells (30), and in-
jected 200 l of 50 nM Gi1WT, Gi1E116L, Gi1Q147L, or
Gi1E245L (in their GDP-liganded forms). Dissociation rates
were determined by fitting the resultant surface plasmon res-
onance sensorgrams (Fig. 3) with a single exponential dissoci-
ation function. RGS12 GoLoco motif-bound Gi1WT,
Gi1E116L, Gi1Q147L, and Gi1E245L were observed to have koff
rates of 1.09, 0.85, 0.79, and 0.78 (1000 s)1, respectively (Fig.
3A). Although the rates of dissociation from the RGS12
GoLoco motif were significantly decreased among all mutants
versusWTGi1, alterations in dissociation rates from the
RGS14 GoLoco motif were more pronounced (Fig. 3B).
Gi1E116L, Gi1Q147L, and Gi1E245L had, respectively, 2-, 3-,
and 4-fold decreases in their rates of dissociation compared
with Gi1WT. Gi1E116L and Gi1Q147L also had significant,
albeit modest, decreases in their rates of dissociation from
GPSM2(GL2), 13.8 and 11.3 (1000 s)1, respectively, com-
pared with 14.8 (1000 s)1 for Gi1WT. By contrast, the rate of
dissociation for Gi1E245L was actually increased slightly to
16.6 (1000 s)1.
Assessment of Nucleotide Binding and Hydrolysis Properties
of the Affinity-enhanced Gi1 Mutants—Using our 2.2-Å crys-
tal structure of the WT Gi1/RGS14 GoLoco motif interface
(Protein Data Bank code 2OM2 (7)), we employed the Rosetta
program to predict mutations with the goal of increasing
GoLoco motif binding affinity while maintaining other G
functionality. To determine whether the Gi1 mutants retain
their ability to bind GTP, we performed radionucleotide-
binding assays with [35S]GTPS. Whereas all three Gi1 mu-
tants were capable of binding GTPS, Gi1E245L had a notice-
ably slower rate of binding (kobs), 0.04 min1 compared with
FIGURE 1. WT Gi1 and three affinity-enhanced mutants bind to the RGS14 GoLoco motif in a nucleotide-dependent manner. Binding isotherms
were generated using FP measurements by increasing the concentration of Gi1 protein while maintaining the concentration of FITC-labeled RGS14
GoLoco motif peptide constant at 350 pM. All experiments were performed in triplicate. The error bars represent S.E. A, Gi1
WTGDP binds the RGS14 GoLoco
motif with a dissociation constant (KD) of 14 nM (95% CI, 11–17 nM). No appreciable binding was observed when the Gi1 protein was in its transition-state
mimetic form, created with AMF. B, Gi1
E245L binds the RGS14 GoLoco motif with KD values of 0.69 nM (95% CI, 0.61– 0.77 nM) and 47 nM (95% CI, 37–56 nM)
in its GDP and GDPAMF forms, respectively. C, Gi1
E116LGDP binds the RGS14 GoLoco motif with a KD of 1.6 nM (95% CI, 1.4 –1.7 nM), whereas no apprecia-
ble binding is observed with the AMF-activated Gi1
E116L. D, Gi1
Q147LGDP binds the RGS14 GoLoco motif with a KD of 2.3 nM (95% CI, 1.9 –2.6 nM), whereas
no appreciable binding is observed in the AMF-activated form. mP, milli-Polarization units.
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0.07, 0.06, and 0.07 min1 for Gi1WT, Gi1E116L, and
Gi1Q147L, respectively (Fig. 4A). To determine any effects on
the intrinsic GTP hydrolysis rate, we also performed single-
turnover [-32P]GTP hydrolysis assays (Fig. 4B). Gi1WT,
Gi1E116L, and Gi1Q147L were observed to have similar kcat
values of 0.48, 0.58, and 0.65 min1, respectively, whereas
FIGURE 2. Gi1 point mutants exhibit enhanced affinity for multiple GoLoco motifs as measured by FP. A–C, log linear binding isotherms were gener-
ated from FP measurements performed in triplicate and obtained by increasing the concentration of Gi1 to 200 nM while the FITC-GoLoco probe concen-
tration was held constant at 350 pM. D, apparent dissociation constants (KD) were calculated using nonlinear regression in GraphPad Prism. Values in paren-
theses represent 95% confidence intervals.
FIGURE 3. Gi1 point mutants exhibit decreased rates of dissociation from GoLoco motif complexes. Surface plasmon resonance sensorgrams were
generated by injecting 200 l of 50 nM WT or mutant Gi1 over immobilized GST-RGS12 GoLoco motif (A), GST-RGS14 GoLoco motif (B), GST-GPSM2(GL2)
(second GoLoco motif of LGN) (C), or GST alone at a flow rate of 40 l/min with a dissociation phase of 2000 s. Dissociation curves are the plotted average of
three independent experiments that have been normalized to percent of maximal binding. D, dissociation rates (koff, expressed as per 1000 s) were derived
from fitting to a single exponential function using GraphPad Prism. 95% confidence intervals are shown in parentheses.
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Gi1E245L had a reduced rate of GTP hydrolysis of 0.15 min1
(95% confidence interval (CI), 0.12–0.17). Despite the rate
changes observed with Gi1E245L, all four Gi1 subunits dem-
onstrated identical rates of activation by aluminum tetrafluo-
ride, as measured by increased Trp-211 intrinsic fluorescence
(supplemental Fig. S3). However, the reduced rates of GTP
binding and hydrolysis exhibited by Gi1E245L led us to ex-
clude this particular mutant from further pursuit.
Assessment of Thermodynamic Binding Parameters of the
Affinity-enhanced Gi1Q147L Mutant—Rosetta makes predic-
tions of changes in Gibbs free energy (G) upon mutation of
single residues, but because there is no explicit entropy term
provided as output from the program, one cannot accurately
predict whether affinity enhancement arises from favorable
enthalpic (H) or entropic (S) thermodynamic changes (40).
We therefore interrogated by isothermal titration calorimetry
which thermodynamic parameter(s) were responsible for the
higher affinity of GoLoco motif binding by Gi1Q147L com-
pared with Gi1WT (Fig. 5). Enthalpy of binding was favorably
exothermic for Gi1Q147L at 7.13 kcal/mol compared with
Gi1WT at 4.14 kcal/mol, whereas entropy decreased unfa-
vorably: 15.6 cal/mol/°C for Gi1Q147L versus 22.0 cal/mol/°C
for Gi1WT (Fig. 5C).
Structural Determinants of the Gi1Q147L Mutant Bound to
the RGS14 GoLoco Motif—To elucidate the structural deter-
minants of GoLoco affinity enhancement for Gi1Q147L, we ob-
tained x-ray diffraction data to 2.38-Å resolution from a single
crystal of the Gi1Q147LGDP/RGS14 GoLocomotif peptide
complex. A structural model was obtained bymolecular replace-
ment using themodel of theWTGi1GDP/RGS14 complex
FIGURE 4. Rates of guanine nucleotide binding and hydrolysis by affinity-enhanced Gi1 mutants. A, nucleotide binding assays were initiated by the
addition of [35S]GTPS to 100 nM WT or mutant Gi1 protein in either assay buffer or nonspecific buffer (the latter with excess unlabeled nucleotide). At the
indicated time points, 100 l of the protein mixture was vacuum-filtered through nitrocellulose, washed four times, and counted by scintillation. Assays
were conducted in duplicate. The error bars represent S.E. Rates of binding (kobs) were determined using nonlinear regression to be 0.07 min
1 (95% CI,





Q147L, respectively. B, intrinsic GTPase activities of WT and mutant Gi1 subunits were determined using [-
32P]GTP single-turnover assays. 100 nM Gi1
protein was loaded with [-32P]GTP at 20 °C for 10 min before assays were initiated by the addition of Mg2 (10 mM) and GTPS (400 M). At the indicated
time points, 100 l of the protein mixture was quenched with activated charcoal, and released [32P]Pi was counted by scintillation. Assays were conducted
in duplicate. The error bars represent S.E. GTPase rates (kcat) were determined using nonlinear regression to be 0.48 min
1 (95% CI, 0.40 – 0.56), 0.15 min1





FIGURE 5. Thermodynamic contributions to RGS14 GoLoco motif binding by WT and Gi1
Q147L subunits as determined by ITC. 30 M solutions of
each indicated Gi1 subunit were separately titrated with repeated additions of 350 M RGS14 GoLoco motif peptide. Calorimetric traces of heat released
and enthalpic binding curves (insets) fitted with a one-site binding model are shown for Gi1
WT (A) and Gi1
Q147L (B). The stoichiometry of binding was 1:1
in all experiments (three independent titrations were performed for each protein). C, average values and 95% confidence intervals for enthalpy of binding
(H) are given for the triplicate titration experiments (p  0.006). Gibbs free energy (G) is calculated from FP binding affinity measurements, and entropy
of binding is derived by S  (H  G)/T.
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(Protein Data Bank code 2OM2) as a searchmodel and subse-
quently refined (supplemental Table S1). The overall conforma-
tions of the Gi1Q147L subunit and bound GoLocomotif peptide
were essentially identical (root mean square deviation of 0.38 Å,
2545 atoms used in comparison) (supplemental Fig. S1) to those
observed in theWT crystal structure (7). The N-terminal helix of
the RGS14 GoLocomotif contacts the Ras-like domain of
Gi1Q147L in a manner similar to theWT structure (Protein Data
Bank code 2OM2 (7)), whereas the N-terminal helix of aWT
structure reported earlier (code 1KJY (13)) is shifted by one half-
turn. The conserved (E/D)QRGoLoco triad (Asp-514, Gln-515,
Arg-516) loops across the nucleotide-binding pocket, positioning
the Arg-516 side chain to contact the - and -phosphate groups
of GDP, and thus inhibits nucleotide dissociation (13). However,
very weak electron density was observed for the preceding three
GoLocomotif residues Gly-511, Ala-512, and His-513 that sur-
round a well defined leucine side chain on Gi1 at position 147
(i.e. site of the Q147L substitution) (Fig. 6). Thus, the placement
of a hydrophobic leucine on the surface of Gi1 appears to lead
to disorder in the surrounding GoLocomotif peptide region.
These findings suggest an increased conformational flexibility of
the RGS14 GoLocomotif peptide in the region of amino acids
511–513 upon binding to Gi1Q147L compared withWTGi1.
Modeling of the Q147L Substitution by Monte Carlo
Simulations—The Gi1Q147L/GoLoco crystal structure sug-
gest that residues 511–513 may be more dynamic in the mu-
tant than in WT Gi1, and therefore, an increase in confor-
mational entropy may contribute to the enhanced affinity of
Gi1Q147L for GoLoco motifs. However, the ITC results show
that the net change in the entropy component upon binding
(Fig. 5) is more favorable for WT Gi1 than for Gi1Q147L. In
general, it is very difficult to predict relative changes in bind-
ing entropies and enthalpies because enthalpy/entropy com-
pensation is a dominant feature of solvated systems (41).
Changes in water networks in either the bound or unbound
state could change the number of hydrogen bonds within the
system and also change the rotational freedom of each water.
Given our observation of disorder within the RGS14 GoLoco
motif, we used Rosetta loop modeling simulations to examine
the structural preferences of GoLoco motif residues 510–513
when bound to either Gi1WT or Gi1Q147L. For each case,
100 independent structure prediction simulations were per-
formed. With WT Gi1, all 100 simulations predicted a loop
conformation similar to that observed in the crystal structure
(Fig. 7A). However, with Gi1Q147L, two alternative conforma-
tions were observed for residues 510–513 (Fig. 7B). In 40% of
FIGURE 6. Differences in electron density observed within the GoLoco
motif between WT and Q147L mutant Gi1GDP/RGS14 GoLoco motif
complexes. A crystal structure (using diffraction data to 2.38-Å resolution)
of the Gi1
Q147LGDP/RGS14 GoLoco motif complex (Protein Data Bank code
3ONW) was obtained. Overall, the Gi1
Q147L protein binds the RGS14
GoLoco motif protein similarly (root mean square deviation of 0.38 Å) to
Gi1
WT (code 2OM2 (7)). However, electron density for the GoLoco motif
peptide residues Gly-511, Ala-512, and His-513 is much weaker in the
Gi1
Q147L structure (B) than in the WT structure (code 2OM2) (A), indicating
disorder in the peptide surrounding the mutated Gi1 residue Leu-147.
Both 2Fo  Fc electron density maps shown are contoured at   1.5.
FIGURE 7. Rosetta loop modeling predictions for the RGS14 GoLoco motif bound to Gi1
WT and Gi1
Q147L. Six representative models are shown from
100 independent structure prediction trajectories. GoLoco motif residues 510 –513 are shown in stick mode. Gln-147 (A) and Leu-147 (B) are shown in space
filling representation. Nitrogens are colored blue, and oxygens are colored red.
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the models, residues 510–513 adopt a conformation similar
to the WT structure; in the other 60%, residues 511 and 512
are displaced by 	4 Å. The alternate conformation places the
backbone groups adjacent to bothmethyl groups on the Gi1
residue Leu-147. The solvation energy term in Rosetta disfavors
the alternate conformation for Gi1WT because both the nitro-
gen and oxygen atoms of Gln-147 are desolvated without the
formation of a compensating hydrogen bond. These results are
consistent with the poor electron density observed for residues
511–513 in the GoLoco/Gi1Q147L crystal structure.
Conclusions—Our findings confirm the ability of Rosetta to
predict point mutations that enhance protein/protein binding
affinities, a technique that should be readily applicable to
other systems with high-resolution structural information
available (7). Furthermore, our findings have provided insight
into the kinetic, thermodynamic, and structural mechanisms
underlying the favorable accommodation of affinity-enhanc-
ing mutations. Two of the three Gi1 mutants studied
(Gi1Q147L and Gi1E116L) exhibit enhanced binding to
GoLoco motifs without disrupting guanine nucleotide binding
or hydrolysis functions (an important consideration for their
utility in examining selective G activities in an integrated
cellular context). The selective loss of GoLoco motif binding
of the Gi1N149I point mutant was instrumental in establishing
direct involvement of a Gi/GoLocomotif complex inmicrotu-
bule dynamics underlying spindle orientation and chromosomal
segregation during cell division (25). Other groups have since
employed the Gi1N149I mutant to demonstrate that cell polar-
ization-mediated spatial restriction of spindle orientation deter-
minants is critical for epithelial morphogenesis (26) and that the
multiple-GoLocomotif protein AGS4may couple G subunits
to receptor-proximal events affected by agonist application (42).
The verified gain-of-functionmutants Gi1Q147L and Gi1E116L
described in this work should complement the loss-of-function
Gi1N149I mutant and find equal utility in investigating the role
of G/GoLocomotif interactions in asymmetric cell division,
epithelial progenitor differentiation, and G-protein-coupled re-
ceptor signaling regulation.
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